Skip to main content

Thomas Joseph Weber

Professor of Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
Duke Box 3470, Durham, NC 27710
303 Baker House, Durham, NC 27710

Overview


Osteoporosis, with current studies that focus on advances in diagnosis and natural history of male and postmenopausal osteoporosis. The study on male osteoporosis include a collaborative study with outside investigators is examining the utility of lateral spine bone densitometry in identifying men with osteoporosis and low trauma fractures.

Hypophosphatemic disorders, including X-link hypophosphatemic rickets and tumor-induced osteomalacia. My ongoing research study, in collaboration with Dr. L Darryl Quarles at the University of Kansas, seeks to further confirm and extend our understanding of the role of FGF-23 in human disorders of phosphate homeostasis, including patients with chronic kidney disease. Pending studies include primary and sub-investigator directed Phase 1 / 2 first in human studies examining the effects of a monoclonal antibody and enzyme replacement therapy for X-linked hypophosphatemic rickets and hypophosphatasia, respectively.

Current Duke Appointments & Affiliations


Professor of Medicine · 2021 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine
Member of the Duke Cancer Institute · 2016 - Present Duke Cancer Institute, Institutes and Centers

Recent Scholarly Works


Secondary fracture prevention after vertebral, femur or pelvic fracture at US academic medical center.

Journal article Arch Osteoporos · March 5, 2026 UNLABELLED: This study sought to assess rates of osteoporosis treatment following an index fragility vertebra, femur, or pelvic fracture at a US academic medical center. The results highlight persistent low treatment rates following fracture and emphasize ... Full text Link to item Cite

Switching from active vitamin D and phosphate supplementation to burosumab significantly corrects lower limb malalignment in pediatric X-linked hypophosphatemia.

Journal article J Bone Miner Res · November 29, 2025 X-linked hypophosphatemia (XLH) is a rare disorder of renal phosphate wasting and dysregulated active vitamin D metabolism, ultimately presenting as rickets and osteomalacia, among other manifestations. Lower extremity deformity (genu valgum and/or varum) ... Full text Link to item Cite

Clinical Pearls From JCEM Case Reports: ENDO 2025.

Journal article JCEM Case Rep · November 2025 Full text Link to item Cite
View All Scholarly Works

Recent Grants


Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029

X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP) UX023-CL401

ResearchPrincipal Investigator · Awarded by Ultragenyx Pharmaceutical · 2018 - 2028

Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism

ResearchCollaborator · Awarded by National Institutes of Health · 2023 - 2025

View All Grants

Education


The University of Chicago · 1989 M.D.